Tumour regression and survival of patients with disseminated malignant melanoma treated with chemotherapy and specific active immunotherapy
- 1 October 1977
- journal article
- research article
- Published by Elsevier
- Vol. 13 (10) , 1169-1173
- https://doi.org/10.1016/0014-2964(77)90017-2
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Malignant melanoma and immunotherapy.BMJ, 1976
- Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanomaBritish Journal of Cancer, 1976
- Combination chemotherapy for disseminated malignant melanomaCancer, 1975
- Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot studyBritish Journal of Cancer, 1975
- Comparison of the combination of 1, 3-bis(2-chloroethyl)-l-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-l-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanomaCancer, 1975
- Evaluation of l-(2-chloroethyl-3-4-methylcyclohexyl)-l-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45388) and vincristine (NSC 67574) in palliation of disseminated malignant melanomaCancer, 1974
- Effect of Active Immunization with Irradiated Tumour Cells on Specific Serum Inhibitors of Cell-mediated Immunity in Patients with Disseminated CancerBritish Journal of Cancer, 1973
- Chemotherapy of malignant melanomaCancer, 1972
- Immunization with Irradiated Tumour Cells and Specific Lymphocyte Cytotoxicity in Malignant MelanomaBMJ, 1971